Thyrocare Technologies Limited (BOM:539871)
349.75
-10.60 (-2.94%)
At close: Mar 30, 2026
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 55.67 billion as of March 31, 2026. Its market cap has increased by 52.03% in one year.
Market Cap
55.67B
Enterprise Value
53.99B
Revenue
7.92B
Ranking
n/a
PE Ratio
39.96
Stock Price
349.75
Market Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 55.67B, an increase of 67.67%. That is a compound annual growth rate of 5.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 55.67B | -21.58% |
| Dec 31, 2025 | 70.99B | 46.48% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| One Global Service Provider | 10.03B |
| Chandan Healthcare | 5.65B |
| Modern Diagnostic & Research Centre | 856.58M |
| Invicta Diagnostic | 817.18M |
| Star Imaging and Path Lab | 806.37M |
| Aspira Pathlab & Diagnostics | 563.54M |
| Family Care Hospitals | 141.52M |
| Dr Lalchandani Labs | 127.91M |